Tag: $Tern Pharmaceuticals

Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal

Merck to pay a 6% premium to buy the outstanding shares of Terns Pharmaceuticals, which is developing an oral treatment for leukemia.